source
- Abbott nabs FDA approval, CE Mark for implantable cardioverter-defibrillator leadAbbott has received both FDA and CE Mark approval for its UltiSynq defibrillation lead tech, which is designed to deliver both conduction system pacing and defibrillation therapy.
- Emory researchers identify 10-protein blood panel that detects ALS with 98% accuracyResearchers at Emory University have reported a new blood test that could spot amyotrophic lateral sclerosis much earlier than current methods. By measuring a set of ten proteins in plasma, the tes…